肺动脉高压患者肺康复转诊频率与预测因素:PHA注册研究分析
本研究基于肺动脉高压协会注册数据库,回顾性分析成人肺动脉高压(PAH)患者肺康复(PR)转诊频率及预测因素。结果显示第一、二、三次随访时PR转诊率分别为17.0%、26.6%、32.3%,转诊与年龄、性别、种族、地区、病因、疾病严重程度、吸氧及肺移植转诊独立相关;转诊患者中不足半数实际参与PR,且仅参与PR与健康相关生活质量改善相关。
要点
- PAH患者PR转诊率在三次随访中分别为17.0%、26.6%、32.3%。
- 转诊与种族、地区、病因、REVEAL Lite 2.0评分、吸氧及肺移植转诊独立相关。
- 转诊患者中不足半数实际参与PR,仅参与PR与HRQOL改善相关。
核心结论
- 尽管PR益处明确,PAH患者PR转诊率仍低,且受人口学、社会经济因素及疾病特征显著影响。
- PR转诊与PR参与不平行,仅参与PR与HRQOL改善相关。
研究设计与样本
- 回顾性队列研究,纳入肺动脉高压协会注册的成人PAH患者。
- 比较第二次随访前转诊PR的患者与从未转诊PR的患者。
主要发现
- PR转诊率在第一次、第二次、第三次随访时分别为17.0%、26.6%、32.3%。
- 转诊患者年龄更大(58.3±15.3 vs 55.2±15.6;P<.001),女性比例更高(81.9% vs 75.9%;P=.02)。
- 转诊患者在种族、地理区域、就业状态和PAH病因方面存在差异。
- 转诊患者功能分级、风险分层、HRQOL和6分钟步行距离更差,补充氧疗使用率更高,但肺血流动力学和PAH治疗使用相似。
- 多变量分析中,种族、地区、PAH病因、REVEAL Lite 2.0评分、补充氧疗使用和肺移植转诊与PR转诊独立相关。
临床怎么用
- 应关注PAH患者PR转诊的低频率,尤其针对年龄较大、功能状态较差、使用补充氧疗等可能受益人群。
- 需解决人口学和社会经济因素对PR转诊的影响,并促进转诊后实际参与PR。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pulmonary arterial hypertension (PAH) is a complex cardiopulmonary disease associated with exertional dyspnea and impaired health-related quality of life (HRQOL) despite medical therapy. Pulmonary rehabilitation (PR), a supervised exercise program for patients with chronic lung disease, improves symptoms, HRQOL, and exercise capacity. Despite these benefits, there is a paucity of data regarding PR in PAH. RESEARCH QUESTION: What is the frequency of PR referrals among patients with PAH, and what factors are associated with PR referrals? STUDY DESIGN AND METHODS: We performed a retrospective cohort study of adults with PAH enrolled in the Pulmonary Hypertension Association Registry. Patients referred to PR by the time of the second follow-up visit were compared with patients never referred to PR. RESULTS: PR referral rates were 17.0%, 26.6%, and 32.3% at the first, second, and third follow-up visits, respectively. Patients referred to PR were older (58.3 ± 15.3 vs 55.2 ± 15.6; P < .001), more likely to be female (81.9% vs 75.9%; P = .02), and exhibited differences in race, geographic region, employment status, and PAH etiology. Referred patients had worse functional class, risk stratification, HRQOL, and 6-minute walk distance with higher rates of supplemental oxygen use and similar pulmonary hemodynamics and use of PAH therapy. In multivariable analysis, race, region, and PAH etiology and disease severity as assessed by REVEAL Lite 2.0 scores, supplemental oxygen use, and lung transplantation referral were independently associated with PR referral. In a subgroup analysis, less than one-half of patients referred to PR reported participation in PR within the preceding 6 months. PR participation, but not PR referrals, was associated with improvements in HRQOL. INTERPRETATION: Despite well-established benefits, this study indicates that referral to PR is low among patients with PAH and is significantly impacted by demographic and socioeconomic factors as well as disease characteristics.
引用
- Bailey M, Frantz R, Minhas J, et al. The Frequency and Predictors of Pulmonary Rehabilitation Referrals Among Patients With Pulmonary Arterial Hypertension: An Analysis of the Pulmonary Hypertension Association Registry. Chest. 2025. PMID: 40306406. doi:10.1016/j.chest.2025.04.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。